Press release
Dengue Fever Clinical Market to Reach USD 6.4 Billion by 2030
Dengue Fever Clinical
The market includes diagnostics, treatment, vaccines, supportive care, surveillance systems, and clinical management services-playing a crucial role in reducing morbidity and controlling outbreaks.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73628
Key Takeaways
• Market Size 2023: USD 3.2 billion
• Market Size 2030: USD 6.4 billion
• CAGR (2024-2030): 9.8%
• Largest Segment: Diagnostics (NS1, IgM/IgG, PCR)
• Fastest-Growing Segment: Vaccine development & clinical trial commercialization
Market Story
Dengue fever, transmitted by Aedes aegypti and Aedes albopictus mosquitoes, has become one of the fastest-growing mosquito-borne viral diseases globally. Over 50% of the world's population is at risk, and annual cases continue to rise significantly.
This growing burden is driving demand across:
• Rapid diagnostic tests (RDTs)
• Serological assays (IgM/IgG)
• Molecular diagnostics (RT-PCR)
• Point-of-care testing devices
• Antiviral drug research
• Supportive clinical care
• Vaccination programs
• Hospital-based dengue management systems
Governments, NGOs, and international health agencies are investing heavily in surveillance, outbreak control, and vaccine development-fueling strong market momentum.
Market Segments
By Product Type
• Diagnostics (Largest Segment)
- NS1 antigen tests
- IgM/IgG antibody tests
- PCR kits
- Point-of-care diagnostics
• Vaccines (Fastest Growing)
• Supportive Treatment Products
- Hydration fluids, platelet support, analgesics
• Antiviral Drug Development Pipeline
• Surveillance & Monitoring Systems
Diagnostics dominate due to rapid outbreak detection requirements.
By Diagnostic Technique
• Serological Tests (IgM/IgG)
• NS1 Antigen Detection Tests (Largest Adoption)
• RT-PCR Molecular Tests
• Microfluidic Point-of-Care Tests
• ELISA-Based Detection
NS1 tests remain the primary clinical diagnostic tool in early-stage dengue.
By End User
• Hospitals & Clinics (Largest End User)
• Diagnostic Laboratories & Centers
• Public Health Agencies
• Research Institutes & Universities
• NGOs & Community Health Organizations
Hospitals lead due to growing case admissions during peak dengue seasons.
By Application
• Clinical Diagnosis
• Outbreak Surveillance
• Vaccine Administration Programs
• Drug Discovery & Clinical Trials
• Public Health Monitoring
Surveillance systems are increasingly funded to prevent large-scale urban outbreaks.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73628/dengue-fever-clinical-market
Recent Industry Developments
• 2024 - Takeda expanded availability of its dengue vaccine QDENGA® in multiple high-burden countries.
• 2023 - WHO endorsed wider use of dengue diagnostics in endemic regions.
• 2023 - Abbott launched advanced rapid antigen detection kits for early dengue detection.
• 2023 - Roche Diagnostics enhanced PCR-based dengue testing for reference labs.
• 2023 - Sanofi progressed clinical trials for next-generation dengue vaccines after Dengvaxia's restricted rollout.
Expert Quote
"Dengue is no longer seasonal-it is now a year-round public health challenge. Increasing global infections are driving strong demand for accurate diagnostics, effective clinical management, and next-generation vaccines."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
1. Rising Global Burden of Dengue
More than 100 countries report annual outbreaks due to changing climate and urbanization.
2. Expansion of Diagnostics & Point-of-Care Testing
Early diagnosis reduces hospitalization and fatality rates.
3. Growth in Vaccine Development Efforts
Pharma companies and governments are actively pursuing broader immunization strategies.
4. Increased Awareness & Surveillance
NGOs and public health agencies heavily invest in outbreak monitoring and community testing.
5. Government-Led Dengue Control Programs
Initiatives such as fogging, vector management, and early detection increase market demand.
Forecast Outlook (2024-2030)
Key future trends include:
• AI-based mosquito tracking and outbreak prediction
• Integration of mobile diagnostic devices for decentralized testing
• Wider availability of multi-serotype vaccines
• Digital monitoring dashboards for hospitals
• Increased investment in antiviral drug discovery
By 2030, global dengue management will rely heavily on rapid diagnostics, vaccine adoption, and improved clinical treatment infrastructure.
Regional Insights
Asia-Pacific (Largest Market & Highest Disease Burden)
India, Indonesia, Thailand, Philippines, Vietnam, and Malaysia face repeated large outbreaks.
Latin America
Brazil, Mexico, Colombia, and Peru show rising case numbers and expanded diagnostic usage.
Middle East & Africa
Growing incidence due to climate shifts and cross-border population movement.
North America & Europe
Cases mainly imported, but diagnostic demand rises during peak travel seasons.
Conclusion
The Dengue Fever Clinical Market is set for strong growth as global health systems prioritize fast diagnosis, effective clinical care, and vaccine accessibility. With rising infection rates and expanding public health investments, the market will become critical in shaping the future of mosquito-borne disease management.
This report is also available in the following languages : Japanese (デング熱の臨床市場), Korean (뎅기열 임상 시장), Chinese (登革热临床市场), French (Marché clinique de la dengue), German (Dengue-Fieber-Klinikmarkt), and Italian (Mercato clinico della febbre dengue), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73628
Related Reports
Global Chlorphenamine Maleate API Market
https://exactitudeconsultancy.com/reports/60953/global-chlorphenamine-maleate-api-market
Global Antipyretic and Analgesic Raw Materials Market
https://exactitudeconsultancy.com/reports/61191/global-antipyretic-and-analgesic-raw-materials-market
Global Yellow Fever Vaccines Market
https://exactitudeconsultancy.com/reports/63821/global-yellow-fever-vaccines-market
Fever Cooling Patch Market
https://exactitudeconsultancy.com/reports/64727/fever-cooling-patch-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Fever Clinical Market to Reach USD 6.4 Billion by 2030 here
News-ID: 4293193 • Views: …
More Releases from Exactitude Consultancy
Protein Expression Market to Reach USD 8.7 Billion by 2030
The Global Protein Expression Market is experiencing significant growth as biotechnology, pharmaceuticals, contract manufacturing, and academic research intensify their focus on recombinant protein production. According to Exactitude Consultancy, the market is expected to rise from USD 4.1 billion in 2023 to USD 8.7 billion by 2030, expanding at a healthy CAGR of 10.9%.
Protein expression technologies enable the production of therapeutic proteins, enzymes, antibodies, vaccines, and research-grade proteins-making them essential tools…
Ready-to-Use Pharmaceutical Packaging Market to Reach USD 14.1 Billion by 2030
The Global Ready-to-Use (RTU) Pharmaceutical Packaging Market is expanding rapidly as biopharmaceutical companies, CDMOs, vaccine manufacturers, and injectables producers shift toward sterile, prevalidated, and fill-finish-ready packaging formats. According to Exactitude Consultancy, the market is expected to grow from USD 6.1 billion in 2023 to USD 14.1 billion by 2030, registering an impressive CAGR of 11.7%.
RTU packaging-prewashed, depyrogenated, sterilized, and ready for aseptic filling-reduces contamination risks, improves output efficiency, eliminates complex…
Next Generation Sequencing Market to Reach USD 32.6 Billion by 2030
The Global Next Generation Sequencing (NGS) Market is witnessing rapid expansion as genomics becomes central to diagnostics, oncology, drug discovery, and personalized medicine. According to Exactitude Consultancy, the market is expected to increase from USD 11.7 billion in 2023 to USD 32.6 billion by 2030, growing at an exceptional CAGR of 15.8%.
NGS delivers high-throughput, cost-efficient, and extremely precise genetic data-transforming healthcare, biomedical research, public health surveillance, and clinical decision-making.
Download Full…
Automated Cell Processing System Market to Reach USD 8.41 Billion by 2030
The Global Automated Cell Processing System Market is growing rapidly as cell therapies, gene therapies, stem cell treatments, and advanced regenerative medicine move toward large-scale clinical and commercial adoption. According to Exactitude Consultancy, the market is projected to rise from USD 2.9 billion in 2023 to USD 8.41 billion by 2030, expanding at a robust CAGR of 16.4%.
Automated cell processing systems streamline and standardize cell isolation, expansion, activation, washing, concentration,…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
